http://investorshub.advfn.com/boards/read_msg.aspx?message_id=49117029
Bayer has paid them an upfront fee. I'm not sure that they need money to develop products at this point. Bayer will do that for them in the near term, and they will receive income from sales. So their expenses will be mostly administrative at this point, and the royalties may pay for SSRC to develop their own products.
The question as to equity financing depends on the stock price. So once SSRC hits the spotlight and gets analyzed, what will they be worth? Bayer is already working on the same process, fooling insects by disrupting their sense of smell. They think enough of Sentisearch's technology to partner with them, and on SSRC's terms, imo, in a research and product development agreement. What if it works, and there is a whole new type of green pesticide developed from this collaboration? I believe Sentisearch would have a much higher market cap than the $4.7 million it has now. Possibly much, much higher.
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM